Work as Analyst-Forecasting at Novartis - MBA with Graduate / Post Graduate in Pharmacy

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Analyst-Forecasting

Job Description:
• Provide forecasting support to Novartis internal customers (CPOs & Regional marketing and sales teams) on various low-medium complexity forecasting reports.
• Support and facilitate data enabled decision making for Novartis internal customers by providing and communicating qualitative and quantitative analytics.
• Support GBS-GCO business in building practice by involving in various initiatives like knowledge sharing, on-boarding and training support, support team lead in all business related tasks / activities, building process documentation and knowledge repositories.
• Create and deliver below customer requirements as per agreed SLAs (timeliness, accuracy, quality, etc) and drive excellent customer service
o Strategic 5 year forecasts for in-line / pipeline products
o Lifecycle management forecasts for inline / pipeline products
o BD&L market & product revenue forecasts
o Pipeline product forecasts
o Monthly revenue forecasts by indication for 24 months
o Ad-hoc Forecasting support
• Deliver services through structured project management approach with appropriate documentation and communication throughout the delivery of services
• Support in creation and maintenance of standard operating procedures (SOPs), quality checklists that will enable excellent quality outputs for all outputs within the function
• Support in developing and maintaining knowledge repositories that captures qualitative and quantitative reports of brands, disease areas, macroeconomic trends of Novartis operating markets, etc
• Support team leaders in recruitment and on-boarding of new associates within the organization
• Participate in various knowledge sharing sessions that enables growth and improves quality of GCO Hyd deliverables across the function
• Comply with all internal functional operating procedures like time tracking, KPI tracking and reporting, and other internal systems and processes
• Comply to all Novartis operating procedures as per legal / IT / HR requirements.

andidate Profile:
MBA with Graduate / Post Graduate in Medicine (MD/MBBS/BDS) Pharmacy / Life Sciences Fluency in English is prerequisite, while knowledge of other in-scope country languages would be an advantage
- Experience (2-3 years) in forecasting in a market research firm or pharmaceutical company or Pharma KPO
- Should have an understanding of Pharmaceutical business including its regulatory environment
- Strong analytical thinking with problem solving approach
- Should have worked in an international company with exposure to working in cross-cultural environment
- Should be customer service oriented
- Strong and proactive business results-focus, and proven ability to provide insights that increase productivity

Additional Information:
Job ID: 153543BR
Experience: 2-3 Year
Industry Type: Pharma/Biotech/Clinical Research
Functional Area: other
End Date: 9^th Dec, 2014

APPLY THROUGH RECTRUITERS PORTAL>>

Drug inspector coaching

India to double drug inspectors to boost oversight

 India will spend 30 billion rupees ($511 million) and double the number of drug inspectors in the next three years to meet global manufacturing standards, the country's health regulator said on Wednesday.

A rash of import bans imposed by the U.S. Food and Drug Administration on leading Indian generic drugmakers due to lapses in production processes over the past year has triggered concerns about the quality of drugs sold in other markets, including in India.

The government will increase the number of inspectors at the Central Drugs Standard Control Organization (CDSCO) to 1,000 from 500 now, Drugs Controller General of India G.N. Singh said in a statement on Wednesday.

The number of officials at state regulatory departments will be raised to 3,000 from 800 now, he said.

"India's reference system (for drug testing and intellectual property) will be at par with the top world standards in two to three years and will even match the U.S. in three to five years," Singh said.

In India, states regulate the manufacture and distribution of drugs, while CDSCO, which is the federal authority, handles approvals of new drugs and clinical trials, oversees drug imports and coordinates the activities of state regulators.

A chronic shortage of inspectors has made it difficult for regulators to monitor the more than 10,000 drug manufacturing factories in India, which supply to more than 200 countries.

Multiple state drug regulators told Reuters in April that skeletal staff and lack of enough drug testing laboratories had rendered their departments unequipped to carry out their duties.

($1 = 58.7600 Indian Rupees)

(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)